Online training: Hepatitis C in Primary Care

ASHM, August 2020

This training aims to provide participants with the knowledge and confidence to pursue the management of HCV in their primary care setting.

Primary care providers can play a critical role in the elimination of hepatitis C in Australia by 2030.

This workshop will provide an overview of the management of HCV in primary care
settings, including case finding, testing, patient assessment and treatment.

Learning Objectives:

• Identify priority populations for HCV screening
• Order and interpret tests appropriately to diagnose chronic HCV infection
• Describe the recommended pre-treatment assessment
• Demonstrate understanding of antiviral therapy for treatment of HCV
• Communicate confidently with patients about HCV

Webinar Presenter: Dr Alireza Ahmavand, General Practitioner, Arafura Medical Clinics – Casuarina

Target Audience:
General Practitioners, Nurse Practitioners, nurses, primary care-based practitioners
and other health care workers.

When: Wednesday 19 August 2020 7.30pm – 9.00pm AEST  (7 – 9.30 pm ACST)

Delivered online, free

This activity is allocated 3 activity points in the RACGP QI&CPD Program for the
2020-2022 Triennium.

For further details or assistance contact: Molly Stannard

 

New COVID Taskforce website from ASHM

ASHM, UPDATED ON: 14 April 2020

ASHM’s Taskforce on BBVs, Sexual Health and COVID-19 was established on 20 March 2020. It provides a timely opportunity for the BBV and sexual health sectors to discuss the scientific, clinical, BBV and sexual health service delivery and social implications of COVID-19, and provides consistent and evidence-based messaging to the health workforce, sector partners and community.

The website contains interim recommendations on:

  • adults living with HIV
  • adults living with chronic hepatitis B.
  • adults living with hepatitis C, or the complications of previous hepatitis C infection
  • people who are incarcerated in criminal justice settings during the COVID-19 pandemic including those who are living with HIV, hepatitis B and hepatitis C.

 

STI/BBV testing tool for asymptomatic people

NSW STI Programs Unit, ASHM & Qld. Govt.,  2019

This resource has charts and information about how routine STI/BBV testing can be offered, who to, and how to follow up.

Developed by NSW STI Programs Unit, NSW Australia, and reproduced with permission by the Sunshine Coast Hospital and Health Service, ASHM and Communicable Diseases Branch.

 

 

A guide to My Health Record: for BBV & STI healthcare providers to support their patients

ASHM  (Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine)

Healthcare providers can play a crucial role in helping patients make informed decisions about whether and indeed the extent, to engage with the My Health Record, particularly for those patients with BBVs and/or other potentially stigmatising conditions.

To support those conversations, ASHM has created A guide to My Health Record: for BBV & STI healthcare providers to support their patients. The guide outlines the key issues associated with My Health Record, and provides four key recommendations to clinicians around advising patients on how to engage with the system.

Though the opt-out period ends soon, clinicians still have an ongoing obligation to provide advice to patients around the benefits as well as the privacy and security control options available, to guide their decision-making around engaging with My Health Record.

With increased media attention on My Health Record in recent weeks, some specifics of the system may change. A guide to My Health Record is a living document and will be updated with any relevant changes as further details emerge.

HIV PrEP update & HIV prescriber update in Adelaide

ASHM, October 2018

HIV PrEP Update for GPs and Practice Nurses

This training will provide GPs, Nurses, and Health Professionals working in primary care an update on strategies available for the prevention of HIV transmission, focusing on prevention particularly pre-exposure prophylaxis (PrEP).

– Date Tuesday, 23 October 2018
– Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA 5000
– Time 6:15pm – 9:30 pm (Registration from 6:15pm, webinar broadcasts from 6:45pm)

At the end of this update, participants will be able to;
– Describe HIV epidemiology in Australia and the different HIV prevention
strategies
– Explain the role of HIV treatment and management
–  Provide patient education on the effectiveness and appropriate use of
PrEP/PEP
– Identify the prescribing pathways of PrEP within your local jurisdiction

This evening educational session will be presented by Dr Charlotte Bell, Sexual
Health Physician – Royal Adelaide Hospital.

This course is also available as a webinar, please contact Emma Williams here
for webinar registration

Register for this course at:
http://www.ashm.org.au/training/
Registrations close: Friday, 19 October 2018

Download flyer here: HIV PrEP Update_23Oct2018


HIV s100 Prescriber Dinner Update: 2018 IAS Conference Report Back and
Complex HIV Case Discussion

ASHM would like to invite HIV s100 Prescribers and medical practitioners in South Australia to attend this dinner training.

– Date Wednesday, 24 October 2018
– Venue Mercure Grosvenor, 125 North Terrace, Adelaide SA 5000
– Time 6:15pm – 9:30 pm (Registration starts 6:15pm, Webinar from 6:50pm)
– Cost FREE, Dinner and refreshments will be provided on site

This dinner workshop will bring attendees an overview of the content showcased at the
2018 International AIDS Conference held in Amsterdam, as well as a number of complex HIV cases to discuss. The first session is a conference report back
session. Professor Mark Boyd will provide an update on the latest studies, important
developments and best research methods in the ongoing battle against HIV, AIDS and
related infectious diseases from the IAS Conference 2018.

The second session will be an interactive panel discussion, focussing on the
management of complex HIV cases. Panellists include Professor Mark Boyd, Dr Russell Waddell (Consultant Sexual Health Physician and Clinical Director STD Services, Royal Adelaide Hospital) and Dr Andrew Beckwith (Senior Consultant Psychiatrist, Director of Training, HIV/Hep C Liaison Psychiatrist, CALHN Mental Health). The session will be hosted by Dr Samuel Elliott (Principal General Practitioner, Riverside Family Medical Practice).

This course is also available as a webinar, please contact Emma Williams here
for webinar registration

Register for this course at:
http://www.ashm.org.au/training/
Registrations close: Friday, 19 October 2018

Download flyer here: HIV Prescriber Update_24Oct2018

The time for action on Human T-Lymphotrophic Virus has arrived: An open letter to WHO

Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine (ASHM), 10 May 2018

ASHM has joined the call by leading Human T-Lymphotrophic Virus 1 (HTLV-1) researchers, clinicians and patients to take action on HTLV-1 by signing an open letter to the WHO, published in an abbreviated form in The Lancet. The letter calls on the WHO to support the promotion of proven, effective transmission prevention strategies for HTLV-1, in much the same way it already does for HIV, HBV and HCV.

ASHM established an 2016, to bring together researches, clinicians and community representatives at an annual round table to raise awareness of HTLV-1 and share the latest information. Up to 40% of the  HTLV-1 working group ipopulation of some Central Australian communities are positive for HTLV-1, which can cause cancer, neurological problems and immune disorders, including chronic lung inflammation leading to bronchiectasis.

“Specifically for Australia, we have all of the key components required for an effective response to this virus – indigenous clinical leadership; the medical research skills and capacity; and two forthcoming developments in treatment and vaccine development,” said Professor Damian Purcell, Head of Molecular Virology Laboratory, The University of Melbourne at the Doherty Institute and member of the ASHM HTLV-1 working group.

“But we need the support of the WHO and Australian Government to accelerate research and implement these strategies.”

ASHM have been advocating for the inclusion of HTLV-1 in the yet-to-be released Fifth National Aboriginal and Torres Strait Islander Blood-Borne Viruses and Sexually Transmissible Infections Strategy as a Priority Action.

Read the full letter available on the Global Virus Network website